1) Fcα/μreceptor
Fcα/μ受体
2) μ receptor
μ受体
1.
Changes of the spinal opioid μ receptors and NMDA receptors during the development of morphine tolerance;
脊髓阿片μ受体和NMDA受体在吗啡耐受过程中的变化
2.
To distinguish the types of receptors distributed in MHb and LHb by using the agonists of μ receptor DAMGO, and σ receptor DPDPE.
以DAGO(μ受体激动剂 ) ,DPDPE(σ受体激动剂 )区分MHb ,LHb分别含有的阿片受体类型。
3) mu opioid receptor
μ受体
1.
Immunohistochemistry localization of mu opioid receptor in the digestive system and several organs of exterior structure of the Octopus ocellatus;
短蛸消化系统和部分器官中μ受体的免疫组织化学定位
4) μ-opioid receptor mRNA
μ受体mRNA
1.
The expression of μ-opioid receptor mRNA in the brain tissue of morphine withdrawal rats was examined by RT-PCR,and effects of EA at Zusanli(ST36) on the body weight and expression of μ-opioid receptor mRNA of morphine withdrawal rat were observed.
方法建立自然吗啡戒断大鼠模型,运用RT-PCR方法测定脑组织μ受体mRNA的表达,观察电针足三里对吗啡戒断大鼠体重及μ受体mRNA表达的影响。
5) μ-receptor
μ受体
1.
Aim To investigate the effects of progesterone on morphine rewarding effect and levels of μ-receptor in hippocampus and striatum.
目的观察孕酮对于吗啡所致奖赏效应及海马和纹状体μ受体水平的影响。
6) μ opioid receptor
μ阿片受体
1.
Dependent potency of endomorphin-1 and its regulation of μ opioid receptor;
内吗啡肽1的依赖潜力及其对μ阿片受体的调节
2.
Objective:To investigate the effects of agmatine by activation I1 imidazoline receptor on DAMGO-induced down-regulation and internalization of μ opioid receptor(MOR).
目的:观察胍丁胺通过激活I1咪唑啉受体(I1R)对阿片预处理引起的μ阿片受体(MOR)下调的影响及可能的分子基础。
3.
Objective To investigate the synaptic connections between endomorphin-immunoreactive(ir) terminals and μ opioid receptor-ir neurons in the superficial layers(laminae Ⅰ and Ⅱ) of the rat spinal dorsal horn.
目的观察大鼠脊髓背角内吗啡肽阳性终末与μ阿片受体阳性神经元的突触联系。
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条